Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL153479

AMBROXOL
🧪 Phase III
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase III
Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1

Basic Information

ChEMBL ID CHEMBL153479
Name AMBROXOL
Phase Phase III
Structure Type MOL
InChI Key JBDGDEWWOUBZPM-XYPYZODXSA-N

Known Names

Ambroxol Tabcin
4
Targets
7
Activities
3
Assay Types
0
PK Parameters
20
Publications
2
Known Names
8
Indications

Molecular Properties

378.1
MW (Da)
3.19
ALogP
3
HBA
3
HBD
58.3
PSA (Ų)
0.71
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Single Enantiomer

Flags

Natural Product

Extended Properties

Molecular Formula C13H18Br2N2O
MW 378.11
Aromatic Rings 1
Heavy Atoms 18
NP-Likeness -0.34

Indications

Parkinson Disease Pharyngitis Respiratory Tract Diseases Amyotrophic Lateral Sclerosis Cough Dementia Gaucher Disease Lewy Body Disease

ATC Classification

R02AD05
ambroxol
Level 1: RESPIRATORY SYSTEM
Level 2: THROAT PREPARATIONS
R05CB06
ambroxol
Level 1: RESPIRATORY SYSTEM
Level 2: COUGH AND COLD PREPARATIONS

Activity Summary

IC50 5 meas. best 6.25
EC50 1 meas. best 4.53
Ki 1 meas. best 5.74

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Cytochrome P450 2D6
CHEMBL289
IC50 6.25 6.25 557.4 1
Sodium-dependent serotonin transporter
CHEMBL228
Ki 5.74 5.74 1802.0 1
Sodium-dependent serotonin transporter
CHEMBL228
IC50 5.47 5.47 3391.0 1
Lysosomal acid glucosylceramidase
CHEMBL2179
IC50 5.39 5.39 4100.0 1
Unchecked
CHEMBL612545
IC50 5.09 4.8 8100.0 2
Lysosomal acid glucosylceramidase
CHEMBL2179
EC50 4.53 4.53 29400.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.1007/s00044-011-9961-1 Cavia porcellus 12
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 5
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 5
37468498 10.1038/s41467-023-40064-9 Cannabinoid receptor 1 5
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 5
22762530 10.1021/jm3006178 ADMET 4
22762530 10.1021/jm3006178 Lysosomal acid glucosylceramidase 4
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 4
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 4
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 4
38932616 10.1021/acs.jmedchem.4c00702 Lysosomal acid glucosylceramidase 3
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 3
37468498 10.1038/s41467-023-40064-9 Androgen receptor 3
20014752 10.1021/tx900326k Hepatotoxicity 3
37468498 10.1038/s41467-023-40064-9 D(1A) dopamine receptor 3
37468498 10.1038/s41467-023-40064-9 Progesterone receptor 3
33395289 10.1021/acs.jmedchem.0c01664 Unchecked 3
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Kappa-type opioid receptor 2

Data from ChEMBL 36 via Core Engine